Peer Review History
| Original SubmissionApril 7, 2020 |
|---|
|
PONE-D-20-09945 MANTA, an integrative database and analysis platform that relates microbiome and phenotypic data PLOS ONE Dear Dr. Chen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Lingling An Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This reviewer is not a bioinformatician by training, but has basic understanding. Therefore, the comments are more from a end-user perspective. The article requires substantial rewriting. The reviewer had to jump across manuscript to find and link information. Should follow the pattern of guiding the readers from what the tool is about to how one can use it properly. The introduction is vague and requires restructuring. It can be importance of microbiota, challenges in microbiota data, currently available tools and what MANTA does in more succinct way. MANTA provides an alternative to currently available tools. However, lacks functionality commonly found in tools that were cited in the paper. There are many tools (MicrobiomeAnalyst or Calypso, shiny-phyloseq) which can do more than MANTA. A comparison table of MANTA functionality and other tools the authors mention will be useful. The concept to database is a bit far fetched in this study. As far as I see, it is like other tools e.g. MicrobiomeAnalyst or Calypso where you just upload tables and do analysis. It is somewhat similar to a phyloseq object only that MANTA is implemented in java and stores info in *.db which can have its advantages. However, there is a need to incorporate phylogenetic and sequence information. I would also like the authors to check the analysis options that are provided by tool called Main (still testing phase). https://www.biorxiv.org/content/10.1101/416073v1 For MANTA to have application for broader analysis, it should have provision for making database using ASV sequences. In this way you can compare across studies to identify common ASVs for analysis. OTU-taxonomy based approach is not recommended (Callahan et al. 2017 PMID: 28731476). For e.g. if I have first project for cancer and healthy microbiota for which I have ASVs sequence abundances and another project for IBD and healthy microbiota, I should be able to analyse these together for a meta analysis. This would be the advantage of having a database like structure. The advantage will be that the web server of authors may not be overloaded by analyzing raw reads but still has high utility because sequence information is stored for every project. This can be organized at user level where only specific user who owns the data can access all their projects that have been processed in similar way. For research groups that do not have data scientists, they can still do basic analysis that MANTA provides. What they need is advanced analysis with well written documentation and tutorials to guide such analysis. e.g Machine learning random forests etc. Minor comments: Through out the article please use the term microbiome and microbiota appropriately, see https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-015-0094-5. In addiiton, the name of the tool can be changed to its betterment as the name MANTA has been used previously. manta http://www.bioconductor.org/packages/release/bioc/html/manta.html manta: https://msystems.asm.org/content/5/1/e00903-19 In summary, I see great potential for the tool but it requires substantial improvements for having a wider impact or usefulness. Reviewer #2: This manuscript provides a well-designed website to analyze microbiome datasets. The key idea is to provide a graphical interface to enable users to browse or analyze their own data or the example datasets. To my understanding, this work has overlapping features with MicrobiomeAnalyst. Thus the validity of the innovation is not clear. I have also listed other issues as follows. 1. The website (https://mizuguchilab.org/manta-example/#en_heatmap) does not function well (Mac Mojave). It always shows “An error occurred while attempting to contact the server. Please check your network connection and try again.” I cannot test this database as a reviewer. 2. The online account system is probably incomplete. Users cannot register. This limits the use of MANTA website to only its developers. 3. I am not clear which function is uniquely available for MANTA and not in other software/websites. 4. The authors claims that MANTA is ‘an integrative database’. As database should allow users to create, read, update, or delete data entries, I do not see MANTA currently support these functions in its website. 5. For ordinal parameters, how the correlation is calculated and visualized? 6. “The assigned ranks and names were searched against the TargetMine data warehouse… ” TargetMine seems to be a gene analysis website developed by the same first author. I am not clear how this website can be used for searching microbiome names. 7. There is no download link for “MANTA basic”. I cannot find the download link and cannot test it either. Reviewer #3: The manuscript describes a website, MANTA, that can be used to store user-uploaded information and perform analysis through web-based user interface. That being said, I encountered some difficulties when I was trying this website and cannot evaluate whether the website is good-to-go or not (will be described below). So I mostly comment on the manuscript itself, trying to guess what the authors were trying to do and how it should look like. Below please find my comments. 1. This is about the website itself. When I want to try this website by clicking on the link in the example dataset tab (https://mizuguchilab.org/manta-example/), the system popped up a message saying that “An error occurred while attempting to contact the server. Please check your network connection and try again”. Due to this I cannot evaluate the full functionality of this website. Please see attached Figure 1 for a screenshot. 2. From the description of the manuscript it looks like the users can upload some information and conduct some analysis by themselves. The tutorial also offers such helps. I however do not see the same figure as shown in the tutorial, in which users are supposed to upload their own data through “Data management” menu items but I just cannot see such thing exists (see attached Figure 2). Two possible reasons may be that the website is down when I was trying to test it, or that there are certain problems associated with the website. I suggest the authors carefully check their websites before submitting their manuscript. 3. The manuscript claims that it is able to relate microbiome and phenotypic data. Yet the functionality that they supported is simply invoking existing R commands/libraries on the datasets without providing novel insights. Furthermore, while the authors claim that they want to develop a website for people not familiar with running programs on command line-based platforms, they still require the microbiota to be analyzed and the OTUs extracted before submitting the data to the MANTA website. This creates a dilemma—researchers that can run the microbiota analysis by themselves do not need their website for phenotypic correlation analysis, and that people who do not know how to run commands cannot analyze microbiota as the authors require. I hence doubt the very existence meaning of the MANTA website and hope that the authors can very carefully think and discuss with non-computational scientists about their needs. 4. The authors are mixing up 16S-based methods with whole-metagenome-based methods, as seen when they are talking about tools such as QIIME, MEGAN, Kraken, and Metaphlan2. The web-based systems that they talked about are mostly whole-metagenome-based methods as well. I suggest the authors at least distinguishing to their best effort between 16S and whole-metagenome and/or discussing their potential uses toward their own systems. 5. There is not “Data preprocessing section” as mentioned in line 96. 6. I am not very sure why the authors mention “free text” in line 101 as one of their parameter forms. I frankly do not think their system can deal with free text according to their description of the website functionalities. Maybe they just want to raise a possible example. If this is the case then this part needs to be re-written in order not to confuse the readers. 7. The authors talked about converting absolute abundances to relative ones for analysis purpose (line 108). Pardon me, but to the best of my knowledge common software packages provide mostly proportions. Therefore I have no idea why the authors want to claim this function. 8. For the description of the case study in Methods, the authors should provide more details, including when the 20 Japanese adults study was conducted. The authors may also want to explain why only a subset of parameters was released. (hence that perhaps not all data are publicly available for publication or review purpose) 9. The analysis pipeline using QIIME was not up-to-date. I understand that some people still use QIIME instead of QIIME2 since they are quite different in some sense; however the SILVA database is outdated. I also don’t understand what the authors mean by mentioning “the taxonomy hierarchy is continuous refined and updated…we reconstructed the phylogenetic lineages using the NCBI taxonomy database (line 143-145).” This part is vague at best, and I honestly do not know what their purposes to “reconstruct” the SILVA-based taxonomic inferences are. Please check your pipeline and conduct the analysis using the most up-to-date datasets/software/versions. 10. The authors mention that the parameters that they are able to asses are “limited to continuous variables (line 200)”. I wonder why they set such restrictions. Does it also mean that their system cannot handle nominal or categorical data? 11. I highly suggest the authors check QIIME2 visualization support since a lot of functionalities that they claim are already supported by QIIME2, for example the coloring of sample points according to the numerical or nominal parameters (line 238). 12. The resolutions of the figures are very poor. Please consider making higher quality ones. 13. Due to poor figure quality and the inability to test the website, I cannot tell whether the authors provide significance metrics such as p-value/FDR or adjust R-squared. Please consider adding such metrics in order to help your users interpreting data if these are not supported. 14. The authors claim that “for users who wish to use the platform for analyzing their data, we also developed MANTA basic.” This is also very intriguing since it hinted that the existing MANTA website only supports the display of the 20-Japanese data, and that the users need to install their own system if they want to analyze their data. If this is true then I honestly do not know the existence meaning of the MANTA website. Please clarify if this is the case. 15. I don’t understand what does “parameter grouping” mean during the comparison between MANTA and MANTA Basic. Please clarify. 16. (line 173) pageable --> do you mean scrollable? 17. (line 192) 10 most abundant will --> 10 most abundant ones will ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-09945R1 MANTA, an integrative database and analysis platform that relates microbiome and phenotypic data PLOS ONE Dear Dr. Chen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 30 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Lingling An Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I appreciate the changes authors have made in the revised MS. Thank you for clarifying my queries and restructuring the manuscript. If possible, the authors must give a statement indicating their plans on how long is the tool expected to be supported and maintained given the funding they have. This is important because many tools after publication are forgotten by developers. I hope that this tool will be maintained and updated for at least 5-10 years. Reviewer #2: This revision has addressed most of my concerns. I can use the online manta website and the offline software. I suggest improving the documentation by at least provide: 1) How to generate the microbiota file (what software, what file format is accepted)? 2) What file format is expected for user’s phenotype file? 3) Explain “Parameter type”. What does “others” mean? How does MANTA treat “others” compared to other types? The example phenotypic file has 290 variables, and I suggest automatically inferring the parameter types in MANTA. Reviewer #3: Upon this revision I now understand that the website described in the first version of the MANTA manuscript was totally fake--or I should say that it is a useless website only for demonstration purpose. The most critical point, as I identified, is that the installation procedure of the webpage components (jdk, tomcat, postgresql, data preprocessing, gwt compilation, to name just a few) can be much more challenging to users compared to ordinary pipelines. Due to this I do not know why users need to spend efforts to set up their own website--using command line pipelines can be easier than that. Thus, again, I doubt the very existence meaning of MANTA. I have said it in my first review but allow me to say it again: please think and discuss with non-computational guys (or just let them try) in order to know their needs. Setting up a website can also be challenging even for people working on computational tasks. Please ponder the needs of non-computational people and design the system/pipeline accordingly. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
MANTA, an integrative database and analysis platform that relates microbiome and phenotypic data PONE-D-20-09945R2 Dear Dr. Chen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Lingling An Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: This revision has addressed all my concerns. In the future, I hope that the authors can continue maintaining the website and add more microbiome projects in the MANTA database. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-09945R2 MANTA, an integrative database and analysis platform that relates microbiome and phenotypic data Dear Dr. Chen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Lingling An Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .